Faculty

R. Scott McClelland

Professor, Epidemiology
Professor, Medicine - Allergy and Infectious Dis.
Professor, Global Health

206-543-4278

Education

MD Medicine, University of Washington, 1995
MPH Epidemiology, University of Washington, 2001
BS Biology, University of Washington, 1989

Contact

206-543-4278

University of Washington
Box 359909
325 9th Avenue
Seattle, WA 98104

Bio

Dr. McClelland is a Professor of Epidemiology, Medicine, and Global Health. He leads a trainee-driven research program linking Seattle and Kenya in collaboration with the Fred Hutchinson Cancer Research Center and the University of Nairobi (UON). Dr. McClelland's research spans a range of topics in HIV, STIs, women's health, key populations epidemiology, clinical trials, and implementation research.

Research Interests

  • Impact of periconceptual vaginal microbiota on women's risk of preterm birth 
  • Randomized trial of an implementation science tool to integrate HIV testing into family planning services in Mombasa County, Kenya 
  • Motivation matters! Randomized trial of theory-based, SMS to support treatment as prevention in high-risk women 
  • Development of a point of care cervical cancer diagnostic platform for low-resource settings 
  • Validation of collection Methods for high risk HPV Detection 
  • Women's life course events & HIV transmission potential: A multidisciplinary study

Recent Publications (PubMed)

Study protocol for the: HIV enhanced access testing in emergency department program using a systems analysis and improvement approach (HEATED-SAIA) cluster randomized trial.
(2026 May 19)
Implement Sci Commun
Aluisio AR, Loevinsohn G, Chondo E, Nderitu A, Bruba M, Adam A, Baird J, Galárraga O, Wilson-Barthes M, Sarker M, Mandaliya K, Kinuthia J, Bosire R, Wachira B, Gross Z, Cherutich P, Wanje G, McClelland RS, Eastment MC
Efficacy and durability of immediate versus delayed single-dose HPV vaccination for persistent infection among young women in Kenya: a randomized, blinded, cross-over clinical trial.
(2026 May 11)
Nat Commun
Barnabas RV, Brown ER, Bukusi EA, Njoroge B, Winer RL, Galloway DA, Wakhungu IN, Biwott C, Kimanthi S, Heller KB, Krows M, Morrison S, Rechkina EA, Cherne SL, McClelland RS, Mugo NR, Onono MA
High agreement of Seegene Anyplex(TM) HPV 28 and Allplex(TM) HPV 28 for High-Risk Vaccine-Type HPV Detection in the KEN SHE Study.
(2026 Apr 8)
J Virol Methods
Heller KB, Mohamed JS, Cherne SL, Onono M, Bukusi EA, Njoroge BW, Kimanthi S, Hassan RM, Rechkina EA, McClelland RS, Brown ER, Mugo NR, Barnabas RV, KEN SHE Study Team
Understanding the cervicovaginal immune response to Lactobacillus crispatus CTV-05.
(2027 Jan 27)
Lancet Microbe
Sabo MC, Shah JA, Lund JM, McClelland RS
A mixed-methods assessment of individual client-level and clinic-level factors associated with uptake of cervical cancer screening (CCS) services in family planning (FP) clinics receiving an intervention to support these services in Mombasa County, Kenya.
(2026 Jan 9)
Implement Sci Commun 7(1): 21
Oyaro B, Wanje G, Richardson BA, Temmerman M, McClelland RS, Eastment M
Show complete publication list